A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 238 participants.
Also called NCT05496361
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 238 participants
- Registry
-
NCT05496361
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05496361. Randomized; single masking; primary purpose treatment. Start 2021-01-24 (actual); primary completion 2021-11-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke
- Condition
- AIS
- Condition
- Acute Ischemic Stroke
- Condition
- Large Vessel Occlusion
- Condition
- Thrombectomy
- Intervention (Device)
- Tianyi Revascularization Device
- Intervention (Device)
- Solitaire FR Revascularization Device
- Lead sponsor
- Suzhou Zenith Vascular SciTech Limited
Record details
- Record id
cardio:ct-nct05496361- Content hash
65b65cb97a14dbcf649696f6b162225116e465a6438fbeed561a067649d274db